573
Views
10
CrossRef citations to date
0
Altmetric
Reviews

The role of tandem stem cell transplantation for multiple myeloma patients

, , , , , , & show all
Pages 515-534 | Received 19 Nov 2015, Accepted 22 Dec 2015, Published online: 06 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Fortunato Morabito, Giovanni Tripepi, Enrica Antonia Martino, Ernesto Vigna, Francesco Mendicino, Lucio Morabito, Katia Todoerti, Hamdi Al-Janazreh, Graziella D’Arrigo, Filippo Antonio Canale, Giovanna Cutrona, Antonino Neri, Massimo Martino & Massimo Gentile. (2021) Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma. Drug Design, Development and Therapy 15, pages 2969-2978.
Read now
Massimo Martino, Marco Rossi, Anna Ferreri, Barbara Loteta, Antonella Morabito, Tiziana Moscato, Giuseppe Console, Vanessa Innao, Virginia Naso, Pasquale Fabio Provenzano, Anna Grazia Recchia & Massimo Gentile. (2019) Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials. Expert Review of Hematology 12:8, pages 665-684.
Read now
Massimo Martino, Anna Grazia Recchia, Giuseppe Console, Massimo Gentile, Michele Cimminiello, Giuseppe Alberto Gallo, Anna Ferreri, Virginia Naso, Giuseppe Irrera, Giuseppe Messina, Tiziana Moscato, Ernesto Vigna, Iolanda Donatella Vincelli & Fortunato Morabito. (2017) Can we improve the conditioning regimen before autologous stem cell transplantation in multiple myeloma?. Expert Opinion on Orphan Drugs 5:11, pages 875-887.
Read now
Dimitrios C. Ziogas, Evangelos Terpos & Meletios A. Dimopoulos. (2017) When to recommend a second autograft in patients with relapsed myeloma?. Leukemia & Lymphoma 58:4, pages 781-787.
Read now

Articles from other publishers (6)

Khalid Ahmed Al-Anazi, Ziyad Alshaibani & Panagiotis Kalogianidis. 2023. Recent Updates on Multiple Myeloma. Recent Updates on Multiple Myeloma.
Mary Jane Sneyd, Andrew R. Gray & Ian M. Morison. (2021) Trends in survival from myeloma, 1990–2015: a competing risks analysis. BMC Cancer 21:1.
Crossref
Shanhao Tang, Yin Lu, Pisheng Zhang, Dong Chen, Xuhui Liu, Xiaohong Du, Junjie Cao, Peipei Ye, Lieguang Chen, Shuangyue Li, Keya Sha, Xian xu Zhuang, Yiyu Xie, Xiaojin Wu & Renzhi Pei. (2021) Lenalidomide, bortezomib and dexamethasone followed by tandem- autologous stem cell transplantation is an effective treatment modality for multi-hit multiple myeloma. Leukemia Research 110, pages 106710.
Crossref
Daniel Lysak, Michaela Brychtová, Martin Leba, Miroslava Čedíková, Daniel Georgiev, Pavel Jindra, Tomáš Vlas & Monika Holubova. (2021) Long-Term Cryopreservation Does Not Affect Quality of Peripheral Blood Stem Cell Grafts: A Comparative Study of Native, Short-Term and Long-Term Cryopreserved Haematopoietic Stem Cells. Cell Transplantation 30, pages 096368972110360.
Crossref
Kate Randall, Maria Kaparou, Evgenia Xenou, Shankara Paneesha, Bhuvan Kishore, Alexandros Kanellopoulos, Richard Lovell, Kathy Holder, Julie Suhr, Lynda Baker, Lynn Ryan & Emmanouil Nikolousis. (2017) Reduced‐intensity conditioning allogeneic transplantation after salvage treatment with DT ‐ PACE in myeloma patients relapsing early after autologous transplant . European Journal of Haematology 99:4, pages 300-305.
Crossref
Jiusheng Deng, Dongkyoo Park, Mengchang Wang, Ajay Nooka, Qiaoya Deng, Shannon Matulis, Jonathan Kaufman, Sagar Lonial, Lawrence H. Boise, Jacques Galipeau & Xingming Deng. (2016) BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth. Oncotarget 7:19, pages 27753-27763.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.